ATE412420T1 - Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro - Google Patents
Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitroInfo
- Publication number
- ATE412420T1 ATE412420T1 AT03733748T AT03733748T ATE412420T1 AT E412420 T1 ATE412420 T1 AT E412420T1 AT 03733748 T AT03733748 T AT 03733748T AT 03733748 T AT03733748 T AT 03733748T AT E412420 T1 ATE412420 T1 AT E412420T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosing
- atherosclerotic plaque
- antigen
- vitro
- chain
- Prior art date
Links
- 208000037260 Atherosclerotic Plaque Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 102100025310 Integrin alpha-10 Human genes 0.000 title 1
- 238000000338 in vitro Methods 0.000 title 1
- 108010035006 integrin alpha 10 Proteins 0.000 title 1
- 230000007505 plaque formation Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 4
- 201000001320 Atherosclerosis Diseases 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38874702P | 2002-06-17 | 2002-06-17 | |
| SE0201844A SE0201844D0 (sv) | 2002-06-17 | 2002-06-17 | New methods and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412420T1 true ATE412420T1 (de) | 2008-11-15 |
Family
ID=29738562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03733748T ATE412420T1 (de) | 2002-06-17 | 2003-06-16 | Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050255182A1 (de) |
| EP (1) | EP1589986B1 (de) |
| JP (1) | JP2006510576A (de) |
| AT (1) | ATE412420T1 (de) |
| AU (1) | AU2003239030A1 (de) |
| CA (1) | CA2488423A1 (de) |
| DE (1) | DE60324471D1 (de) |
| WO (1) | WO2003105886A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60318706T2 (de) * | 2002-06-14 | 2009-04-30 | Cartela R & D Ab | Marker für stammzellen und dessen verwendung |
| BRPI0518328A2 (pt) | 2004-11-22 | 2008-11-11 | Ge Healthcare As | agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica |
| MX2008011261A (es) * | 2006-03-03 | 2008-10-28 | Activbiotics Pharma Llc | Tratamiento de la enfermedad aterosclerotica. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11501662A (ja) * | 1995-10-18 | 1999-02-09 | シーオーアール セラピュティックス インコーポレイテッド | インテグリン−仲介性シグナル変換の調整 |
| AU9016898A (en) * | 1997-08-07 | 1999-03-01 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Methods and compositions for treatment of restenosis |
| AU761430B2 (en) * | 1998-04-02 | 2003-06-05 | Xintela Ab | An integrin heterodimer and a subunit thereof |
| SE0301087D0 (sv) * | 2003-04-14 | 2003-04-14 | Cartela Ab | New monoclonal antibody |
-
2003
- 2003-06-16 AU AU2003239030A patent/AU2003239030A1/en not_active Abandoned
- 2003-06-16 US US10/517,421 patent/US20050255182A1/en not_active Abandoned
- 2003-06-16 WO PCT/SE2003/001012 patent/WO2003105886A2/en not_active Ceased
- 2003-06-16 DE DE60324471T patent/DE60324471D1/de not_active Expired - Fee Related
- 2003-06-16 EP EP03733748A patent/EP1589986B1/de not_active Expired - Lifetime
- 2003-06-16 JP JP2004512787A patent/JP2006510576A/ja active Pending
- 2003-06-16 AT AT03733748T patent/ATE412420T1/de not_active IP Right Cessation
- 2003-06-16 CA CA002488423A patent/CA2488423A1/en not_active Abandoned
-
2008
- 2008-03-07 US US12/073,716 patent/US20080159956A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60324471D1 (de) | 2008-12-11 |
| AU2003239030A1 (en) | 2003-12-31 |
| EP1589986B1 (de) | 2008-10-29 |
| WO2003105886A3 (en) | 2007-11-01 |
| US20050255182A1 (en) | 2005-11-17 |
| CA2488423A1 (en) | 2003-12-24 |
| EP1589986A2 (de) | 2005-11-02 |
| JP2006510576A (ja) | 2006-03-30 |
| US20080159956A1 (en) | 2008-07-03 |
| WO2003105886A2 (en) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69522831D1 (de) | Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie | |
| DE69817698D1 (de) | Verschleisszustandserfassungsvorrichtung für Reifen und Verfahren | |
| ATE458831T1 (de) | Verfahren zum nachweis von lungenneoplasmen in fäkalen proben | |
| ATE489633T1 (de) | Verfahren zum frühzeitigen nachweis herzerkrankungen | |
| ES2188654T3 (es) | Nuevos esteres de acridinio hidrofilos funcionalizados. | |
| DE69836888D1 (de) | Verfahren für Fluoreszenzerkennungstest | |
| ATE429681T1 (de) | System und verfahren zur erkennung von signalartefakten | |
| DE50015973D1 (de) | Messgerät mit Seilsonde und Verfahren zum Kürzen der Seilsonde | |
| DE69939269D1 (de) | Verfahren zur bestimmung der suzeptibilität zur sepsisentwicklung und arzneimittel zur behandlung von sepsis | |
| EP1116029A4 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| ATE317451T1 (de) | Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs | |
| DE59813579D1 (de) | Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen | |
| ATE282831T1 (de) | Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente | |
| EP1643894A4 (de) | Verfahren, kits und antikörper zum nachweis von parathyroid | |
| ATE412420T1 (de) | Verfahren und verwendungszwecke der integrin alpha 10 kette zur diagnose und nachweis von atherosklerotischer plaquebildung in vitro | |
| ATE422334T1 (de) | System und verfahren zur gewebeanalyse | |
| DE69907927D1 (de) | Chemilumineszenz-immunoassay zum nachweis eines mit der chagas-erkränkung verbundenen analyts in einer probe | |
| CY1108512T1 (el) | Μεθοδος και τυποποιημενη συσκευασια για ανιχνευση της αλκαλικης σφιγγομυελινασης | |
| ATE347698T1 (de) | Verfahren zum nachweis von alzheimer-krankheit | |
| ATE449323T1 (de) | Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren | |
| ATE392619T1 (de) | Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen | |
| DE50007635D1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| EP1212600A4 (de) | Diagnostisches reagenz auf der basis von methylen-blau und diagnostischesverfahren zum nachweis von epithel-krebs | |
| HUP0001808A2 (hu) | Antitestek, amelyek a laminin nidogén-kötődoménjéhez kötődnek, előállításuk és alkalmazásuk | |
| ATE543914T1 (de) | Biomarker und verfahren zur bestimmung der empfindlichkeit gegen vegfr2 modulator. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |